BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2821794)

  • 1. Expression of Tac antigen by non-Hodgkin's lymphomas.
    Weiss LM; Michie SA; Medeiros LJ; Strickler JG; Garcia CF; Warnke RA
    Am J Clin Pathol; 1987 Oct; 88(4):483-5. PubMed ID: 2821794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the Leu-8 antigen by B-cell lymphomas.
    Michie SA; Garcia CF; Strickler JG; Dailey MO; Rouse RV; Warnke RA
    Am J Clin Pathol; 1987 Oct; 88(4):486-90. PubMed ID: 3310610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a T-cell antigen (Leu-1) by B-cell lymphomas.
    Burns BF; Warnke RA; Doggett RS; Rouse RV
    Am J Pathol; 1983 Nov; 113(2):165-71. PubMed ID: 6605688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Tac antigen in B cell lymphomas.
    Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
    Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD 25 (Tac antigen) in lymphoid leukemias and non-Hodgkin lymphomas.
    Faure GC; Bene MC; Bolle-Chanal MH
    Eur J Haematol; 1987 Jan; 38(1):26-30. PubMed ID: 3034662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of histologic and immunologic heterogeneity of non-Hodgkin's lymphomas.
    Borowitz MJ; Croker BP; Metzgar RS
    Am J Pathol; 1981 Nov; 105(2):97-106. PubMed ID: 6170233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of leukocyte common antigen in lymphoblastic lymphoma and small noncleaved undifferentiated non-Burkitt's lymphoma: an immunohistochemical study.
    Van Eyken P; De Wolf-Peeters C; Van den Oord J; Tricot G; Desmet V
    J Pathol; 1987 Apr; 151(4):257-61. PubMed ID: 2953875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiinstitution study of non-Hodgkin's lymphomas using frozen section immunoperoxidase: the Southeastern Cancer Study Group experience.
    Borowitz MJ; Newby S; Brynes RK; Cousar JB; Whitcomb CC; Crissman JD; Byrne GE; Collins RD
    Blood; 1984 May; 63(5):1147-52. PubMed ID: 6370333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
    Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
    Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues.
    Davey FR; Gatter KC; Ralfkiaer E; Pulford KA; Krissansen GW; Mason DY
    Am J Pathol; 1987 Oct; 129(1):54-63. PubMed ID: 3310651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
    Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunocytochemical study of T-cell lymphomas using monoclonal and polyclonal antibodies effective in routinely fixed wax embedded tissues.
    Norton AJ; Isaacson PG
    Histopathology; 1986 Dec; 10(12):1243-60. PubMed ID: 3546052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiotypic immunoglobulin secretion by human B cell non-Hodgkin's lymphomas is related to the expression of the interleukin-2 receptor.
    Vyth-Dreese FA; Dellemijn TA; Hekman A; Melief CJ
    Leukemia; 1988 Apr; 2(4):231-5. PubMed ID: 3129622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma.
    Picker LJ; Weiss LM; Medeiros LJ; Wood GS; Warnke RA
    Am J Pathol; 1987 Jul; 128(1):181-201. PubMed ID: 3111266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactivity of CD99 in non-Hodgkin's lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lymphoma.
    Sung CO; Ko YH; Park S; Kim K; Kim W
    J Korean Med Sci; 2005 Dec; 20(6):952-6. PubMed ID: 16361803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.